Challenges in Drug Development

Considerable challenges in drug development, particularly in the face of further organizational changes slated for OGD. A range of legislative and regulatory actions have facilitated consumer access to safe, high-quality generic products, although manufacturing lapses and product quality problems have created critical shortages in important medicines, casting a shadow over the industry's success.

In 2012 the global market for drug development and services reached $3.5 billion. This market is reached $4.5 billion in 2013 and expected to reach 11.7 billion in 2018, a compound annual growth rate (CAGR) of 21.2%.

  • Phase zero trials
  • Mechanism
  • Drug delivery essentials towards better bioavailability

Related Conference of Challenges in Drug Development

October 16-18, 2017

12th World Pharma Congress

Budapest, Hungary
October 16-18, 2017

11th World Drug Delivery Summit

(10 Plenary Forums - 1Event)
Baltimore, Maryland, USA
October 16-17, 2017

10th International Conference and Exhibition on Biologics and Biosimilars

San Francisco, California, USA
November 09-11, 2017

4th European Biopharma Congress

Vienna, Austria
August 20-22, 2018

9th Asian Biologics and Biosimilars Congress

Tokyo, Japan

Challenges in Drug Development Conference Speakers

Recommended Sessions

Related Journals

Are you interested in